Also as shown in Table 1 , the placebo groups had no significant improvement in metabolic parameters, although the BW‐loss group showed a trend towards improvement.
← all excerpts
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH.
1
—
—